These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26571751)

  • 1. [The Cutting-edge of Medicine: Pathophysiology and Management of thrombotic thrombocytopenic purpura].
    Yagi H; Matsumoto M
    Nihon Naika Gakkai Zasshi; 2015 Mar; 104(3):607-14. PubMed ID: 26571751
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.
    Lämmle B; George JN
    Semin Hematol; 2004 Jan; 41(1):1-3. PubMed ID: 14727253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombotic thrombocytopenic purpura].
    Fujimura Y
    Rinsho Ketsueki; 2012 Feb; 53(2):185-95. PubMed ID: 22450578
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent therapeutic strategy for thrombotic thrombocytopenic purpura].
    Fujimura Y; Matsumoto M; Isonishi A; Yagi H; Kokame K; Miyata T
    Rinsho Ketsueki; 2014 Jan; 55(1):93-104. PubMed ID: 24492042
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology of thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2010 Jan; 91(1):1-19. PubMed ID: 20058209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Zheng XL
    Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of thrombotic thrombocytopenic purpura].
    Ueda Y
    Rinsho Ketsueki; 2014 Oct; 55(10):2076-86. PubMed ID: 25297774
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.
    Raife TJ; Friedman KD; Dwyre DM
    Transfusion; 2006 Jan; 46(1):74-9. PubMed ID: 16398733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura.
    Thachil J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2701-2; author reply 2702-3. PubMed ID: 18403435
    [No Abstract]   [Full Text] [Related]  

  • 11. ADAMTS13 and microvascular thrombosis.
    Tsai HM
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):813-25. PubMed ID: 17173498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of thrombotic thrombocytopenic purpura.
    Sadler JE
    Blood; 2017 Sep; 130(10):1181-1188. PubMed ID: 28768626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?
    Kappers-Klunne MC; van Asten JG; van Vliet HH
    Ann Hematol; 2009 Oct; 88(10):1025-8. PubMed ID: 19205653
    [No Abstract]   [Full Text] [Related]  

  • 14. ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.
    Hori Y; Hayakawa M; Isonishi A; Soejima K; Matsumoto M; Fujimura Y
    Transfusion; 2013 Dec; 53(12):3192-202. PubMed ID: 23560518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
    Tsai HM
    J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma Exchange.
    Tsai HM
    Am J Med; 2019 Sep; 132(9):1032-1037. PubMed ID: 30928346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura-what is new?
    Shah N; Sarode R
    J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
    Lämmle B; Kremer Hovinga JA; George JN
    Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
    [No Abstract]   [Full Text] [Related]  

  • 19. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family.
    Kim B; Hing ZA; Wu A; Schiller T; Struble EB; Liuwantara D; Kempert PH; Broxham EJ; Edwards NC; Marder VJ; Simhadri VL; Sauna ZE; Howard TE; Kimchi-Sarfaty C
    Br J Haematol; 2014 Apr; 165(1):154-8. PubMed ID: 24433405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.